Primary ablation for ventricular tachycardia: When and how?

Cardiac Electrophysiology Clinics

Volumn 3, Issue 4, 2011, Pages 675-688

  Santangeli, Pasquale ^a   Di Biase, Luigi ^a,b,c   Al Ahmad, Amin ^d   Hsia, Henry ^d   Burkhardt, J David ^a   Sanchez, Javier ^a   Bai, Rong ^a   Casella, Michela ^e   Russo, Antonio Dello ^e   Tondo, Claudio ^e   Natale, Andrea ^a,b,d,f,g,h  

^a TEXAS CARDIAC ARRHYTHMIA INSTITUTE   (United States)

^b The University of Texas at Austin   (United States)

^c UNIVERSITY OF FOGGIA   (Italy)

^d STANFORD UNIVERSITY   (United States)

^e CENTRO CARDIOLOGICO MONZINO   (Italy)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g SCRIPPS CLINIC   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Cardiac arrest; Catheter ablation; Ventricular tachycardia

Indexed keywords

CATHETER ABLATION; COMPLETE HEART BLOCK; DEEP VEIN THROMBOSIS; DEFIBRILLATOR; EARLY INTERVENTION; HEART FAILURE; HEART TAMPONADE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION; STROKE; SUDDEN DEATH; THERAPY DELAY; TRANSIENT ISCHEMIC ATTACK;

EID: 82755189154     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.08.014     Document Type: Review

References (51)

1. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 2001, 345(20):1473-1482.
2. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114(10):e385-e484.
3. Natale A., Raviele A., Al-Ahmad A., et al. Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol 2010, 21(3):339-379.
4. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51(21):e1-e62.
5. Kamphuis H.C., de Leeuw J.R., Derksen R., et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003, 5(4):381-389.
6. Goldenberg I., Moss A.J., Hall W.J., et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006, 113(24):2810-2817.
7. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102(7):748-754.
8. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008, 359(10):1009-1017.
9. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004, 110(25):3760-3765.
10. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997, 337(22):1576-1583.
11. Sesselberg H.W., Moss A.J., McNitt S., et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007, 4(11):1395-1402.
12. Exner D.V., Pinski S.L., Wyse D.G., et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001, 103(16):2066-2071.
13. Pacifico A., Hohnloser S.H., Williams J.H., et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999, 340(24):1855-1862.
14. Dorian P., Borggrefe M., Al-Khalidi H.R., et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004, 110(24):3646-3654.
15. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006, 295(2):165-171.
16. Calkins H., Epstein A., Packer D., et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group. J Am Coll Cardiol 2000, 35(7):1905-1914.
17. Kuck K.H., Schaumann A., Eckardt L., et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010, 375(9708):31-40.
18. Reddy V.Y., Reynolds M.R., Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007, 357(26):2657-2665.
19. Epstein A.E., Wilber D., Calkins H., et al. Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy. J Am Coll Cardiol 1998, 31(2 Suppl A):118A.
20. Schreieck J., Schneider M.A.E., Röhling M., et al. Preventive ablation of post infarction ventricular tachycardias: Results of a prospective randomized study. Heart Rhythm 2004, 1(Suppl):S35-S37.
21. Niwano S., Fukaya H., Yuge M., et al. Role of electrophysiologic study (EPS)-guided preventive therapy for the management of ventricular tachyarrhythmias in patients with heart failure. Circ J 2008, 72(2):268-273.
22. Rothman S.A., Hsia H.H., Cossu S.F., et al. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997, 96(10):3499-3508.
23. Sacher F., Tedrow U.B., Field M.E., et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol 2008, 1(3):153-161.
24. Stevenson W.G., Friedman P.L., Kocovic D., et al. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998, 98(4):308-314.
25. Strickberger S.A., Man K.C., Daoud E.G., et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator. Circulation 1997, 96(5):1525-1531.
26. Stevenson W.G., Wilber D.J., Natale A., et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 2008, 118(25):2773-2782.
27. Carbucicchio C., Santamaria M., Trevisi N., et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 2008, 117(4):462-469.
28. Sosa E., Scanavacca M., d'Avila A., et al. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996, 7(6):531-536.
29. Morady F., Harvey M., Kalbfleisch S.J., et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993, 87(2):363-372.
30. Tung R., Josephson M.E., Reddy V., et al. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol 2010, 21(7):799-803.
31. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000, 101(11):1297-1302.
32. Sarter B.H., Finkle J.K., Gerszten R.E., et al. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?. J Am Coll Cardiol 1996, 28(1):122-129.
33. Brugada P., Talajic M., Smeets J., et al. The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J 1989, 10(8):747-752.
34. Santangeli P., Di Biase L., Burkhardt J.D., et al. Lesion recovery, epicardial substrate, or new circuit? exploring the dark side of recurrent VT after endocardial ablation. Heart Rhythm Jul 5 2011, [Epub ahead of print].
35. Arnold J.M., Antman E.M., Przyklenk K., et al. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. Am Heart J 1987, 113(5):1055-1065.
36. Miyazaki S., Fujiwara H., Onodera T., et al. Quantitative analysis of contraction band and coagulation necrosis after ischemia and reperfusion in the porcine heart. Circulation 1987, 75(5):1074-1082.
37. Sager P.T., Perlmutter R.A., Rosenfeld L.E., et al. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 1988, 12(1):19-24.
38. Kumar S., Sivagangabalan G., Thiagalingam A., et al. Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart Rhythm 2011, 8(4):493-499.
39. Di Biase L., Burkhardt J.D., Sanchez J., et al. Endo-epicardial homogenization of the scar versus limited endocardial substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. Circulation 2010, 122. A17371.
40. Cochrane Handbook for systematic reviews of interventions, Version 5.0.1. Updated September 2008. The Cochrane Collaboration, 7.7.7.2. Available at: Accessed March, 2010. http://www.cochrane-handbook.org/.
41. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326(7382):219.
42. Borger van der Burg A.E., de Groot N.M., van Erven L., et al. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach?. J Cardiovasc Electrophysiol 2002, 13(5):417-423.
43. Della Bella P., De Ponti R., Uriarte J.A., et al. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Eur Heart J 2002, 23(5):414-424.
44. El-Shalakany A., Hadjis T., Papageorgiou P., et al. Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation 1999, 99(17):2283-2289.
45. Kim Y.H., Sosa-Suarez G., Trouton T.G., et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994, 89(3):1094-1102.
46. O'Callaghan P.A., Poloniecki J., Sosa-Suarez G., et al. Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. Am J Cardiol 2001, 87(8):975-979. A974.
47. O'Donnell D., Bourke J.P., Anilkumar R., et al. Radiofrequency ablation for post infarction ventricular tachycardia. Report of a single centre experience of 112 cases. Eur Heart J 2002, 23(21):1699-1705.
48. Ortiz M., Almendral J., Villacastin J., et al. Rev Esp Cardiol 1999, 52(3):159-168. [in Spanish].
49. Segal O.R., Chow A.W., Markides V., et al. Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm 2005, 2(5):474-482.
50. Tanner H., Hindricks G., Volkmer M., et al. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 2010, 21(1):47-53.
51. Verma A., Marrouche N.F., Schweikert R.A., et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol 2005, 16(5):465-471.